# SymphonyAI

> SymphonyAI is a VC fund in Los Altos backing Health Care and Biotechnology. See 6 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Los Altos, United States
- Total investments: 6
- Last investment: Jan 2024
- Lead investor: 17%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/symphonyai
- X (Twitter): https://twitter.com/SymphonyAI
- Website: http://www.symphonyai.com

SymphonyAI is an enterprise AI company that provides leading AI-centric solutions for transforming the enterprise by driving revenue growth and operational excellence for retail, CPG, healthcare, life sciences, industrial manufacturing, financial, media and entertainment verticals, the public sector, and for IT and other key enterprise horizontalfunctions. The group’s current portfolio is made up of: retail and CPG (Symphony RetailAI), life sciences (ConcertAI), healthcare (TeraRecon), media and entertainment (Symphony MediaAI), industrial manufacturing (Symphony IndustrialAI), financial services (Symphony AyasdiAI), public sector (Symphony Government Solutions) and IT (Symphony SummitAI). Founded by Dr. Romesh Wadhwani, SymphonyAI is one of the fastest-growing companies in the business-to-business AI solutions sector with more than 2,200 employees.

## Contacts

5 contacts available for SymphonyAI. Shizune tracks 7 team members at SymphonyAI. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/symphonyai?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 33% |
| Biotechnology | 2 | 33% |
| Artificial Intelligence | 2 | 33% |
| SaaS | 1 | 17% |
| Medical | 1 | 17% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 17% |
| Series B | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jennifer Trzepacz | Chief People Officer | 0 | https://shizune.co/investors/profile/jennifer-trzepacz |
| Ishan Manaktala | Operating Partner | 0 | https://shizune.co/investors/profile/ishan-manaktala |
| Mark Tice | Operating Partner | 0 | https://shizune.co/investors/profile/mark-tice |
| Pradyut Shah | Partner | 0 | https://shizune.co/investors/profile/pradyut-shah |
| Romesh Wadhwani | Chairman and CEO | 4 | https://shizune.co/investors/profile/romesh-wadhwani |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ansel Health | Ansel Health is a developer of a health insurance platform intended for employers to enhance their employee benefits with a simple supplemental health benefits plan. | $20M | Venture - Series Unknown | Jan 23, 2024 |  |
| Ansel Health | Ansel Health is a developer of a health insurance platform intended for employers to enhance their employee benefits with a simple supplemental health benefits plan. | $15M | Series A | Apr 22, 2021 |  |
| Ansel Health | Ansel Health is a developer of a health insurance platform intended for employers to enhance their employee benefits with a simple supplemental health benefits plan. | $1.5M | Seed | Aug 10, 2020 |  |
| Ansel Health | Ansel Health is a developer of a health insurance platform intended for employers to enhance their employee benefits with a simple supplemental health benefits plan. | $5.5M | Seed | May 21, 2020 |  |
| ConcertAI | ConcertAI is a developer of medical research tool suite intended to design and deliver care-based oncology research and data analytics. It is an integrated real-world data and AI-driven solutions to transform how insights are generated and accelerate therapeutic innovations to patients.It was incorporated in 2018 and is based in Boston,Massachusetts. | $150M | Series B | Jan 13, 2020 |  |
| Precision Health AI | Precision Health AI is a platform technology company focused on applications of AI to Oncology. Serving Pharma, Life Sciences, Providers, and Payers PH.AI combines modern AI technology with best in class oncology data with a focus on improving outcomes and driving value based care. | $20M | Series A | Sep 20, 2017 |  |

6 of 6 investments shown.

## Co-investors
- [Two Sigma Ventures](https://shizune.co/investors/profile/two-sigma-ventures) — VC Fund, 4 deals together
- [Digitalis Ventures](https://shizune.co/investors/profile/digitalis-ventures) — VC Fund, 3 deals together
- [Founder Collective](https://shizune.co/investors/profile/founder-collective) — VC Fund, 3 deals together
- [Brewer Lane Ventures](https://shizune.co/investors/profile/brewer-lane-ventures) — VC Fund, 2 deals together
- [Operator Partners](https://shizune.co/investors/profile/operator-partners) — VC Fund, 2 deals together
- [RGAx](https://shizune.co/investors/profile/rgax) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does SymphonyAI invest in?

SymphonyAI invests primarily in Health Care, Biotechnology and Artificial Intelligence startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact SymphonyAI?

Public channels for SymphonyAI include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at SymphonyAI?

The team at SymphonyAI includes Jennifer Trzepacz (Chief People Officer), Ishan Manaktala (Operating Partner) and Mark Tice (Operating Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co